Gustave Roussy Institut to use blockchain for data in cancer drug trials
The Gustave Roussy Institut, a cancer centre in France, is to deploy blockchain in data-sharing applications for oncology research. The technology will be built in partnership with Embleema, a developer of a healthcare blockchain network, and will be used to improve transparency, patient safety and patient engagement in clinical trials.
Alex Guest Mon, 04/03/2019 - 15:40